EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring Promising Therapies for Advanced Non-Small-Cell Lung Cancer

Ramon Andrade de Mello

Revista da Sociedade Brasileira de Cancerologia · 2024 · 33 (72) · 157-160

DOI: 10.29327/258045.33.72-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista da Sociedade Brasileira de Cancerologia, 2024. Verfasst von Ramon Andrade de Mello. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer persists as a leading cause of cancer-related mortality across the globe, with a discernible rise in incidence among women in both developed and developing regions. Lung cancer is broadly classified into two major subtypes: small-cell lung cancer and non-small-cell lung cancer (NSCLC). NSCLC accounts for approximately 85% of all lung cancers, subdivided into three principal histological types: adenocarcinoma (AC), squamous cell carcinoma (SCC), and large-cell carcinoma. NSCLC is a highly aggressive type of lung cancer that is usually diagnosed at an advanced stage. In this advanced stage, tumors cannot be surgically removed and systemic treatment (chemotherapy, immunotherapy, or targeted therapy) is needed1. Second-line therapy options for patients with advanced NSCLC who had progressed after first-line chemotherapy have substantially changed since the approval of the anti-PD-1 antibody nivolumab and the anaplastic lymphoma kinase (ALK) inhibitor crizotinib. Prognosis for patients with advanced NSCLC is poor, emphasizing the unmet need for novel approaches to treat this disease. Genetic alterations in NSCLC have been extensively investigated in recent years. With the rapid advancement of next-generation sequencing technologies, there is an increase in the number of cancer-associated genomic alterations being discovered. The first success was the identification of EGFR mutations in 2004. Currently, major subgroups of NSCLC patients can

Zitieren

APA

Mello, R. A. D. (2024). Exploring Promising Therapies for Advanced Non-Small-Cell Lung Cancer. Revista da Sociedade Brasileira de Cancerologia, 33(72), 157-160. https://doi.org/10.29327/258045.33.72-3

Vancouver

Mello RAD. Exploring Promising Therapies for Advanced Non-Small-Cell Lung Cancer. Revista da Sociedade Brasileira de Cancerologia. 2024;33(72):157-160. doi:10.29327/258045.33.72-3

BibTeX
@article{Mello2024,
  author = {Mello, Ramon Andrade de},
  title = {Exploring Promising Therapies for Advanced Non-Small-Cell Lung Cancer},
  journal = {Revista da Sociedade Brasileira de Cancerologia},
  year = {2024},
  volume = {33},
  number = {72},
  pages = {157--160},
  doi = {10.29327/258045.33.72-3}
}
Kostenlos starten →